👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Oracle, Nvidia Rise Premarket; Gilead Drops

Published 09/14/2020, 08:03 AM
© Reuters.
MSFT
-
ORCL
-
GILD
-
AMZN
-
NVDA
-
PFE
-
VZ
-
DAL
-
TSLA
-
IMMU
-
AZN
-
BNTX
-
NKLA
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Monday, September 14th. Please refresh for updates.

  • Oracle (NYSE:ORCL) stock rose 7.5% after reports that the tech giant has beaten out rival bidder Microsoft (NASDAQ:MSFT), down 0.7%, to take over the U.S. operations of TikTok, the popular video app. 

  • Nvidia (NASDAQ:NVDA) stock rose 6.1% after agreeing to buy U.K.-based chip designer ARM from Japan's SoftBank for as much as $40 billion, in a deal set to reshape the global semiconductor landscape.

  • Pfizer (NYSE:PFE) stock rose 2.3% after its CEO said over the weekend that it was a “likely scenario” that the pharma giant could have a Covid vaccine to roll out to Americans by the end of the year. The shares of BioNTech (NASDAQ:BNTX), with which Pfizer is jointly developing the vaccine, rose 3.6%.

  • Gilead (NASDAQ:GILD) stock fell 2.3% after announcing it will acquire biopharmaceutical company Immunomedics (NASDAQ:IMMU) for a hefty $21 billion, a move it hopes will strengthen its cancer portfolio by gaining access to a promising drug. Immunomedics stock rose 106%.

  • It comes only weeks after an embarrassing setback for Gilead in late-stage trials of an experimental drug for rheumatoid arthritis.

  • Amazon (NASDAQ:AMZN) stock rose 1.4% after announcing it is recruiting 100,000 more workers, its fourth hiring spree in the United States this year, to keep pace with e-commerce demand that jumped during the pandemic.

  • Tesla (NASDAQ:TSLA) stock rose 1.8%, rebounding after wild swings last week. The stock took a hit from not getting into the S&P 500 at the last index rejig, but some think its inclusion is just a matter of time. 

  • AstraZeneca (NYSE:AZN) ADRs rose 0.7% after the pharma giant announced over the weekend that it has restarted its late-stage trial of its Covid-19 vaccine candidate. It had to stop the trial last week after a patient became unwell.

  • Delta Air Lines (NYSE:DAL) stock rose 1.3% after the airline announced plans for a $6.5 billion capital raise, backed by its frequent flyer program. This likely means the airline won’t be taking more money from the government, with the restrictions that implies.

  • Nikola (NASDAQ:NKLA) stock fell 3%, continuing its recent selloff after Hindenburg Research accused the automotive company of fraud. The company’s founder, Trevor Milton, refuted the claims on his Twitter as “a one-sided false claim”, but the stock continues to fall.
  • Verizon (NYSE:VZ) stock rose 1.4% after announcing it will buy wireless services provider Tracfone, a unit of Mexican telecom America Movil, in a $6.25 billion cash and stock deal.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.